Skip to Content

Logo 4358 300 (Ranitidine Hydrochloride 300 mg)

Pill with imprint Logo 4358 300 is Beige, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Teva Pharmaceuticals USA.

Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 4358 300

Ranitidine hydrochloride 300 mg Logo 4358 300
Ranitidine hydrochloride 300 mg Logo 4358 300
Ranitidine hydrochloride 300 mg Logo 4358 300

Ranitidine Hydrochloride

Imprint
Logo 4358 300
Strength
300 mg
Color
Beige
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00172-4358
Inactive Ingredients
croscarmellose sodium, hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide red, titanium dioxide, triethyl citrate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.